Start with its own history
At 10.84×, ALCGM.PA is 75.7% below its 7-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
PAR · ALCGM.PAMedical - Healthcare Information ServicesUpdated Oct 23, 2026
Cegedim P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
10.84×
75.7% belowthe 7-observation annual average
Share price10.3
÷Earnings per share0.95
Price and EPS in quote currency. Calculation details
Investors are paying 10.84 for every 1 of reported earnings per share.
P/E over time
2015 – 2024
Annual P/ESelected-period average 44.57×
3-year average14.56×1 positive annual observations
5-year average19.96×3 positive annual observations
10-year average44.57×7 positive annual observations
Peer median · TTM10.80×2 peers with positive P/E
Historical P/E ratios
Annual period-end data · 23 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2024 | N/M | N/M |
| Dec 31, 2023 | N/M | N/M |
| Dec 31, 2022 | 14.56× | +15.3% |
| Dec 31, 2021 | 12.63× | -61.4% |
| Dec 31, 2020 | 32.69× | -78.6% |
| Dec 31, 2019 | 152.63× | +216.9% |
| Dec 31, 2018 | 48.17× | +7.6% |
| Dec 31, 2017 | 44.75× | N/M |
View all 23 annual observations +
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2016 | N/M | N/M |
| Dec 31, 2015 | 6.55× | N/M |
| Dec 31, 2014 | N/M | N/M |
| Dec 31, 2013 | N/M | N/M |
| Dec 31, 2012 | N/M | N/M |
| Dec 31, 2011 | 7.39× | N/M |
| Dec 31, 2010 | N/M | N/M |
| Dec 31, 2009 | 9.91× | +17.8% |
| Dec 31, 2008 | 8.42× | -49.5% |
| Dec 31, 2007 | 16.67× | +6.2% |
| Dec 31, 2006 | 15.69× | -69.5% |
| Dec 31, 2005 | 51.50× | +224.9% |
| Dec 31, 2004 | 15.85× | -33.4% |
| Dec 31, 2003 | 23.79× | -0.1% |
| Dec 31, 2002 | 23.81× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How ALCGM.PA compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 ALCGM.PA This stockCegedim | 10.84× |
 ALCOR.PABiocorp Production | N/M |
 ALVMG.PAVisiomed Group S.A. | 19.94× |
 MLAHC.PAHealth S.A. | N/M |
 MKEA.PAMauna Kea Technologies S.A. | 1.66× |
 MLBON.PAbonyf N.V. | N/M |
 MLMIB.PAMetrics in Balance N.V. | N/M |
 COX.PANicox S.A. | N/M |
 FALG.PAFermentalg S.A. | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does ALCGM.PA’s P/E tell you?
Compare like with like
The median of the 2 positive peer ratios above is 10.80×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take ALCGM.PA into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("ALCGM.PA", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 10.3 ÷ EPS 0.95 = 10.84×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Oct 23, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
ALCGM.PA P/E ratio: common questions
The essentials behind the numbers.
Cegedim's current P/E is 10.84× based on the quote data last updated Oct 23, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.